|
Fair Value Measurements (Details) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | 7 Months Ended | 12 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2013
Recurring basis
Significant Other Observable Inputs (Level 2)
Interest rates swaps
|
Dec. 31, 2013
Nonrecurring basis
|
Jul. 23, 2013
Ziegler Healthcare Real Estate Funds
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
|
Dec. 31, 2011
Ziegler Healthcare Real Estate Funds
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Recurring basis
Significant Other Observable Inputs (Level 2)
Interest rates swaps
|
Dec. 31, 2011
Ziegler Healthcare Real Estate Funds
Recurring basis
Significant Other Observable Inputs (Level 2)
Interest rates swaps
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Medical office buildings
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Land
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Property under development
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Fair Value
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Fair Value
Medical office buildings
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Fair Value
Land
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Fair Value
Property under development
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Significant Unobservable Inputs (Level 3)
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Significant Unobservable Inputs (Level 3)
Medical office buildings
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Significant Unobservable Inputs (Level 3)
Land
|
Dec. 31, 2012
Ziegler Healthcare Real Estate Funds
Nonrecurring basis
Significant Unobservable Inputs (Level 3)
Property under development
|
|
| Fair value measurements | ||||||||||||||||||||
| Fair value of derivative | $ (397) | $ (400) | $ (643) | $ (600) | ||||||||||||||||
| Changes in fair value of the derivative | (246) | (200) | (190) | (122) | 325 | (100) | 300 | |||||||||||||
| Assets fair value | 5,474 | 3,589 | 1,210 | 675 | 5,474 | 3,589 | 1,210 | 675 | ||||||||||||
| Assets subject to impairment | 0 | |||||||||||||||||||
| Total Gains (Losses) | $ (937) | $ (615) | $ (232) | $ (90) | ||||||||||||||||